Tissue Regenix, a regenerative medical devices company, named five members to its U.S. orthopedic clinical advisory board, according to Yahoo Finance.
Board members include:
• Steven Arnoczky, DVM, director of the Laboratory for Comparative Orthopedic Research at Michigan State University in East Lansing
• David Caborn, MD, orthopedic surgery clinical professor at University of Louisville (Ky.)
• Thomas Carter, MD, team physician for the NBA Phoenix Suns
• Philip Davidson, MD, founder of Davidson Orthopedics in Salt Lake City
• Jack Farr II, MD, orthopedic surgeon at OrthoIndy in Indianapolis
Tissue Regenix will collaborate with the five board members to commercialize its orthopedic products throughout the United States. The company plans to focus on allograft applications in the U.S. market.
More articles on devices:
NuVasive sentiment falls to 1.17 in Q1: 5 notes
Bioventus files for $150M IPO: 5 points
Prosidyan, MO-SCI collaborate on new orthopedic technology — 5 insights